Success Stories: We Helped a Biomedical Software Engineer from India in the Field of Bioinformatics to Achieve EB-1A Approval in Just a Month
Client’s Testimonial:
“Great, thanks. awesome news!! Thanks for all your help!”
On May 27th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Biomedical Software Engineer in the Field of Bioinformatics (Approval Notice).
General Field: Bioinformatics
Position at the Time of Case Filing: Biomedical Software Engineer
Country of Origin: India
Country of Residence at the Time of Filing: India
Approval Notice Date: May 27th, 2021
Processing Time: 1 month, 6 days (Premium Processing Requested)
Case Summary:
With an M.Sc. in bioinformatics and many years of experience attempting prescient research, there is no doubt that our client possesses the ability to advance in the field of bioinformatics. When he contacted our law firm to file an EB-1A (Alien of Extraordinary Ability) petition on his behalf, we delved more into his degrees and diplomas, and the employment letter confirming his current position before we agreed to take his case. After evaluating his credentials, we confirmed that we would lead him to EB1A success and countersigned the retainer agreement.
Our objective was to prove that he is a keystone researcher in the field of bioinformatics, therefore, we added pivotal attributes in his EB1A petition packet:
- We noted the 833 times his work was cited by dependent and independent researchers, indicating the major significance of his findings to other biomedical software engineers around the world. Not only has he completed and published the results of his research in the field, but his findings have also influenced his counterparts. That is, his publications have been cited by researchers in at least 45 countries, thereby signifying that these publications are widely recognized and relied upon in the field of bioinformatics.
- We also detailed the 29 peer-reviewed scientific articles he published, all of which appeared in some of the most discerning, high-impact journals in his field. Further, we listed the outstanding 10 times our client reviewed the work of his peers. As only the best in the field is invited to judge the work of others, our client’s noteworthy peer review record expressed the magnitude of his reputable status in the field.
- We discussed one of the most important elements of our client’s EB1A petition which is related to his research on the utilization of analytics algorithms and open-source tools for analyzing biomedical data relating to cancer, and we concluded that his efforts address some of the country’s most pressing issues, including applying computational techniques and analytical tools to oncologic research, including cancer pathology, genomic biomarkers, and therapeutic efficacy.
- To bolster our client’s case further, we added recommendation letters signed by six other expert scholars in the field, one of whom stated, “In sum, [client’s] novel research plays a critical role in advancing scientific knowledge towards addressing the challenges present in our current cancer treatment methods and drug therapies. His work has been recognized by both researchers and clinical practitioners, which speaks to its value to the field of bioinformatics and also to wider medical interests. His research continues to have an impact on the improvement of cancer treatments and targeted therapies, and therefore remains vital to medical research within the United States. I am thus pleased to recommend the continuation of his work in this country.”